Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Market price (% of par)
-
90.82%
-
Total 13F principal
-
$324,677,440
-
Principal change
-
-$59,692,986
-
Total reported market value
-
$294,978,957
-
Number of holders
-
42
-
Value change
-
-$55,240,585
-
Number of buys
-
18
-
Number of sells
-
15
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q4 2019
As of 31 Dec 2019,
SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 was held by
42 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$324,677,440
in principal (par value) of the bond.
The largest 10 bondholders included
Allianz Asset Management GmbH, ADVENT CAPITAL MANAGEMENT /DE/, M&G INVESTMENT MANAGEMENT LTD, CAMDEN ASSET MANAGEMENT L P /CA, NN Investment Partners Holdings N.V., JPMORGAN CHASE & CO, Invesco Ltd., WOLVERINE ASSET MANAGEMENT LLC, CALAMOS ADVISORS LLC, and STATE STREET CORP.
This page lists
42
institutional bondholders reporting positions
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.